Search Results 541-550 of 17515 for cannabis
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...
Rochester, Minn. The overall goal of this project is to study a new 3D ultrasound imaging technology for evaluation of axillary lymph nodes in patients with ...
The purpose of this study is to study the handling of ovarian tissue, cryopreservation technology, and oocyte maturation for female pediatric cancer ...
The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival ...
This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...
Discovery's Edge: Rochester Epidemiology Project is a boon for research featured image · Sudden cardiac death of teen reminds physicians of promises, challenges ...
Meet William Bobo, M.D. – taking the guesswork out of finding the right depression therapy. Mayo Clinic Staff. June 10, 2019.
2024 marks a pivotal year for advancing artificial intelligence (AI) solutions in healthcare, requiring multidisciplinary teamwork and scientific rigor to bring ...
Reprint from Mayo Clinic Alumni magazine, 2023, issue 3 Timothy Nelson, M.D., Ph.D., intended to be a cardiothoracic surgeon. “As a student in the Medical ...
ROCHESTER, Minn. — In a new multicenter international study led by the Mayo Clinic Comprehensive Cancer Center, researchers found that people with the B-cell ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!